These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1055482)

  • 1. [Complex therapy of purulent inflammatory diseases of the soft tissues of the face and jaw, using prodigiosan].
    Tsepov LM
    Stomatologiia (Mosk); 1975; 54(2):28-31. PubMed ID: 1055482
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with the treatment of children with suppurative inflammatory processes in the maxillofacial region].
    Chmyrev VS
    Stomatologiia (Mosk); 1974; 53(4):49-51. PubMed ID: 4529134
    [No Abstract]   [Full Text] [Related]  

  • 3. [Specific immunotherapy in the overall treatment of odontogenic inflammatory diseases].
    Biberman IaM
    Stomatologiia (Mosk); 1976; 55(4):30-3. PubMed ID: 1071504
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of proteolyic enzymes and nucleases in the complex treatment of acute and chronic odontogenic inflammatory processes of the maxillofacial region].
    Korchak LF
    Zh Ushn Nos Gorl Bolezn; 1972; (3):75-80. PubMed ID: 4680880
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of a chloracetophos ointment in the combined treatment of acute odontogenic inflammatory processes of the maxillofacial area].
    Khamitov FS; Faizov TT; Berim MG
    Stomatologiia (Mosk); 1985; 64(1):35-7. PubMed ID: 3857735
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in the factors of nonspecific protection of the body during treatment of inflammatory diseases of the maxillofacial area in elderly persons using prodigiozan].
    Zakson ML; Bordonos VG
    Stomatologiia (Mosk); 1987; 66(6):9-11. PubMed ID: 3481503
    [No Abstract]   [Full Text] [Related]  

  • 7. [The use of quercetin granules for treating suppurative soft-tissue wounds of the maxillofacial area and neck].
    Timofeev AA; Maksiutina NP; Voĭtenko GN; Dobrovol'skiĭ IuN
    Stomatologiia (Mosk); 1989; 68(6):11-3. PubMed ID: 2623676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of using baliz-2 for treating suppurative wounds of the soft tissues].
    Timofeev AA
    Sov Med; 1988; (12):116. PubMed ID: 3242110
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of the preparation baliz-2 in inflammatory processes of the maxillofacial area].
    Bernadskaia GP; Timofeev AA; Kutsenko TA
    Stomatologiia (Mosk); 1989; 68(6):10-1. PubMed ID: 2623675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regional lymphotropic antibiotic therapy as a part of comprehensive treatment of children with purulent-inflammatory diseases of maxillofacial region].
    Zhanalina BS
    Stomatologiia (Mosk); 2008; 87(2):70-2. PubMed ID: 18454123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and experimental bases for using dibasol in inflammatory diseases of the maxillofacial area].
    Alekhova TM
    Stomatologiia (Mosk); 1982; 61(1):15-7. PubMed ID: 6950550
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical use of thymalin in the prophylaxis and treatment of infectious-inflammatory diseases of the maxillofacial region].
    Solov'ev MM; Alekhova TM; Sysoeva EN; Morozov VG; Khavinson VKh
    Vestn Khir Im I I Grek; 1981 Dec; 127(12):6-11. PubMed ID: 7340043
    [No Abstract]   [Full Text] [Related]  

  • 13. [The therapy of inflammatory diseases of the maxillofacial area with the use of imidazole derivatives].
    Ushakov RV; Tsarev VN; Dugarov BD; Lopyrev VA
    Stomatologiia (Mosk); 1992; (3-6):31-4. PubMed ID: 1307150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of netromycin in suppurative maxillofacial surgery in children].
    Roginskiĭ VV; Gerchikov LN; Raĭlian SK; Beliaeva EI; Pavelko GA
    Stomatologiia (Mosk); 1994; 73(3):68-71. PubMed ID: 7846723
    [No Abstract]   [Full Text] [Related]  

  • 15. [Supersorbicid in comprehensive treatment of acute pyoinflammatory processes in maxillofacial region].
    Eshbadalov KhIu
    Stomatologiia (Mosk); 2005; 84(2):36-7. PubMed ID: 15798751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differences in the immune status of patients with chronic odontogenic inflammatory processes of the maxillofacial area].
    Robustova TG; Kostishin ID
    Stomatologiia (Mosk); 1986; 65(4):31-3. PubMed ID: 3462977
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bioelectrical activity of the brain in acute and chronic inflammatory diseases of the soft tissues of the face and jaws].
    Tsepov LM
    Stomatologiia (Mosk); 1978; 57(5):39-43. PubMed ID: 279115
    [No Abstract]   [Full Text] [Related]  

  • 18. [Means of decreasing complications in patients with severe inflammatory diseases of the maxillofacial area].
    Zakharova GN; Bulkin VA
    Stomatologiia (Mosk); 1987; 66(3):37-9. PubMed ID: 3475830
    [No Abstract]   [Full Text] [Related]  

  • 19. [The optimization of the regeneration of a suppurative wound in the maxillofacial area by using lymphogenic therapy].
    Shumskiĭ AV; Pozdniĭ AIu; Morozov PV
    Voen Med Zh; 1999 May; 320(5):28-33. PubMed ID: 10401246
    [No Abstract]   [Full Text] [Related]  

  • 20. [Enzyme therapy of patients with pyo-inflammatory disease of maxillofacial area].
    Minaev SV; Ibragimov OR; Zelenskiĭ VA; Minaeva NV
    Voen Med Zh; 2007 Nov; 328(11):25-7, 96. PubMed ID: 18306709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.